Abstract

ABSTRACTPurpose:Bladder tumors are rare in children and adolescents. For this reason, the diagnosis is sometimes delayed in pediatric patients. We aimed to describe the diagnosis, treatment, and follow-up methods of bladder urothelial neoplasms in children and adolescents.Materials and Methods:We carried out a retrospective multicenter study involving patients who were treated between 2008 and 2014. Eleven patients aged younger than 18 years were enrolled in the study. In all the patients, a bladder tumor was diagnosed using ultrasonography and was treated through transurethral resection of the bladder (TURBT).Results:Nine of the 11 patients (82%) were admitted with gross hematuria. The average delay in diagnosis was 3 months (range, 0–16 months) until the ultrasonographic diagnosis was performed from the first episodes of macroscopic hematuria. A single exophytic tumor (1–4cm) was present in each patient. The pathology of all patients was reported as superficial urothelial neoplasm: two with papilloma, one with papillary urothelial neoplasm of low malignant potential (PUNLMP), four with low grade pTa, and four with low grade pT1. No recurrence was observed during regular cystoscopic and ultrasonographic follow-up.Conclusions:Regardless of the presence of hematuria, bladder tumors in children are usually not considered because urothelial carcinoma in this population is extremely rare, which causes a delay in diagnosis. Fortunately, the disease has a good prognosis and recurrences are infrequent. Cystoscopy may be unnecessary in the follow-up of children with bladder tumors. We believe that ultrasonography is sufficient in follow-up.

Highlights

  • Bladder cancer (BC) is the most common malignancy of the urinary tract

  • Nine of the 11 patients were admitted with one or more episodes of gross hematuria and one patient was admitted with abdominal pain

  • Bladder tumors are rare in children and adolescents, it should be considered in the presence of painless gross hematuria

Read more

Summary

Introduction

Bladder cancer (BC) is the most common malignancy of the urinary tract. It is the seventh most common cancer in men and the seventeenth most common cancer in women. The worldwide age-standardized incidence rate is 9 per 100.000 for men and 2 per 100.000 for women (2008 data). According to a recent study, approximately 110 cases have been reported in the literature in this age group since 1950 [2]. These tumors have a low grade of malignancy, showing little tendency toward recurrence and have a good prognosis. We aimed to draw our colleague’s attention to this issue by conducting a multicenter study (three centers) covering data from 11 patients who were diagnosed as having this disease over the last seven years, because we have treated four patients for bladder urothelial neoplasm in our clinic in the last three years

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call